Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Bellone

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Cellular & Molecular Immunology|October 3, 2017
Osteopontin and the immune system: another brick in the wallSara Caputo, Matteo Bellone
Frontiers in Oncology|September 25, 2013
Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytesMatteo Bellone, Arianna Calcinotto
Cancer Immunology, Immunotherapy : CII|June 29, 2012
Vitamin D-binding protein-derived macrophage-activating factor, GcMAF, and prostate cancerMatteo Bellone, Nicolò Rigamonti
Cancer Immunology, Immunotherapy : CII|February 15, 2012
Prostate cancer, tumor immunity and a renewed sense of optimism in immunotherapyNicolò Rigamonti, Matteo Bellone
Cellular & Molecular Immunology|July 18, 2017
Fatty is not that bad: feeding short-chain fatty acids to restrain autoimmunityArianna Brevi, Matteo Bellone
European Urology Oncology|May 5, 2023
Leveraging the Tumor Immune Microenvironment To Overcome Genitourinary CancersMatteo Bellone, Anna Mondino
Journal of Molecular Medicine (Berlin, Germany)|September 16, 2020
ACE polymorphisms and COVID-19-related mortality in EuropeMatteo Bellone, Stefania Laura Calvisi
Cytokine & Growth Factor Reviews|June 14, 2017
Constitutive and acquired mechanisms of resistance to immune checkpoint blockade in human cancerMatteo Bellone, Angela Rita Elia
Oncoscience|October 2, 2015
Immunosuppression via Tenascin-CMatteo Bellone, Sara Caputo, Elena Jachetti
Oncoimmunology|November 20, 2012
Won't you come on in? How to favor lymphocyte infiltration in tumorsMatteo Bellone, Arianna Calcinotto, Angelo Corti
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Cellular & Molecular Immunology|October 3, 2017
Osteopontin and the immune system: another brick in the wallSara Caputo, Matteo Bellone
Frontiers in Oncology|September 25, 2013
Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytesMatteo Bellone, Arianna Calcinotto
Cancer Immunology, Immunotherapy : CII|June 29, 2012
Vitamin D-binding protein-derived macrophage-activating factor, GcMAF, and prostate cancerMatteo Bellone, Nicolò Rigamonti
Cancer Immunology, Immunotherapy : CII|February 15, 2012
Prostate cancer, tumor immunity and a renewed sense of optimism in immunotherapyNicolò Rigamonti, Matteo Bellone
Cellular & Molecular Immunology|July 18, 2017
Fatty is not that bad: feeding short-chain fatty acids to restrain autoimmunityArianna Brevi, Matteo Bellone
European Urology Oncology|May 5, 2023
Leveraging the Tumor Immune Microenvironment To Overcome Genitourinary CancersMatteo Bellone, Anna Mondino
Journal of Molecular Medicine (Berlin, Germany)|September 16, 2020
ACE polymorphisms and COVID-19-related mortality in EuropeMatteo Bellone, Stefania Laura Calvisi
Cytokine & Growth Factor Reviews|June 14, 2017
Constitutive and acquired mechanisms of resistance to immune checkpoint blockade in human cancerMatteo Bellone, Angela Rita Elia
Oncoscience|October 2, 2015
Immunosuppression via Tenascin-CMatteo Bellone, Sara Caputo, Elena Jachetti
Oncoimmunology|November 20, 2012
Won't you come on in? How to favor lymphocyte infiltration in tumorsMatteo Bellone, Arianna Calcinotto, Angelo Corti
Pageof 9